Quantum Diamond Technologies
Quantum Diamond Technologies Inc. specializes in quantum sensing technology for ultrasensitive biomarker detection, diagnostics, and biomedical research. Their platform leverages quantum mechanics and diamond-based NV centers to provide simple, rapid, and highly sensitive detection of proteins, nucleic acids, and cells, with applications in healthcare, drug discovery, and research. The company is committed to advancing quantum technology for impactful biomedical solutions and collaborates with various research institutions and industry partners.
Industries
Nr. of Employees
small (1-50)
Quantum Diamond Technologies
1466 Main Street, 1st Floor, Waltham, MA 02451
Patents
Methods and apparatus for magnetic particle analysis using diamond magnetic imaging
US-10845449-B2
View Details
Methods and apparatus for magnetic particle analysis using diamond magnetic imaging
US-10845449-B2
View DetailsProducts
Diamond NV-center magnetic biomarker detection instrument (benchtop)
Benchtop instrument that images magnetic tags on a diamond NV sensor to quantify proteins, nucleic acids, and rare cells with reported sub-picogram analytical sensitivity and low sample-volume requirements.
Assay kits and consumables for magnetic detection
Ready-made assay kits and consumables compatible with magnetic imaging workflows, covering marker panels for neurology, inflammatory and cardiovascular applications; available for purchase to support the detection platform.
Diamond NV-center magnetic biomarker detection instrument (benchtop)
Benchtop instrument that images magnetic tags on a diamond NV sensor to quantify proteins, nucleic acids, and rare cells with reported sub-picogram analytical sensitivity and low sample-volume requirements.
Assay kits and consumables for magnetic detection
Ready-made assay kits and consumables compatible with magnetic imaging workflows, covering marker panels for neurology, inflammatory and cardiovascular applications; available for purchase to support the detection platform.
Services
Laboratory service accepting submitted samples for ultrasensitive analysis and data delivery using a diamond NV magnetic detection platform; marketed as faster turnaround and guaranteed workflow to prevent sample loss.
Collaborative assay development service including antibody screening, assay prototyping, optimization for specific sample matrices, fit-for-purpose validation, and reagent scale-up for downstream testing.
Laboratory service accepting submitted samples for ultrasensitive analysis and data delivery using a diamond NV magnetic detection platform; marketed as faster turnaround and guaranteed workflow to prevent sample loss.
Collaborative assay development service including antibody screening, assay prototyping, optimization for specific sample matrices, fit-for-purpose validation, and reagent scale-up for downstream testing.
Expertise Areas
- Quantum sensing–based biomarker detection
- Magnetic imaging immunoassays
- Ultrasensitive clinical and research diagnostics
- Assay development and fit-for-purpose validation
Key Technologies
- Nitrogen-vacancy (NV) center diamond quantum sensing
- Diamond magnetometry
- Magnetic bead sandwich immunoassays
- Magnetic nanoparticle analysis
News & Updates
QDTI received a $500,000 grant from MassVentures START program to support commercialization efforts.
DARPA has exercised its option to continue supporting the development of QDTI’s NV diamond imaging technology.
NIST awarded QDTI a Phase II SBIR contract to develop high-speed analysis of magnetic nanoparticles.
A study comparing QDTI's quantum magnetic approach with fluorescent-based Luminex, demonstrating ultrasensitive, simple, and fast biomarker detection.
Research on magnetic resonance spectroscopy with nanoscale resolution using a solid-state spin sensor.
Imaging of single-neuron action potentials with quantum defects in diamond.
QDTI received a $500,000 grant from MassVentures START program to support commercialization efforts.
DARPA has exercised its option to continue supporting the development of QDTI’s NV diamond imaging technology.
NIST awarded QDTI a Phase II SBIR contract to develop high-speed analysis of magnetic nanoparticles.
A study comparing QDTI's quantum magnetic approach with fluorescent-based Luminex, demonstrating ultrasensitive, simple, and fast biomarker detection.
Research on magnetic resonance spectroscopy with nanoscale resolution using a solid-state spin sensor.
Imaging of single-neuron action potentials with quantum defects in diamond.